Vienna, Austria

Michael Seifert

This inventor holds 1 USPTO granted patent. Top assignees: Boehringer Ingelheim Rcv Gmbh & Co. Kg, Sandoz Ag. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael Seifert. Retrieved from https://idiyas.com/inventor/michael-seifert-tsf3e7n0

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Michael Seifert

Introduction

Michael Seifert is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of affinity ligands, which are crucial in various biochemical applications. His innovative work has led to the development of a unique affinity matrix that enhances the efficiency of biochemical processes.

Latest Patents

Michael Seifert holds a patent for an affinity matrix comprising a solid phase and an affinity ligand with peptide bonds. This ligand is selected from a specific group of peptides and poly-amino acids, designed to optimize binding properties. His patent includes detailed specifications regarding the composition and structure of these ligands, ensuring their effectiveness in various applications. He has 1 patent to his name.

Career Highlights

Throughout his career, Michael has worked with prominent companies in the pharmaceutical and biotechnology sectors. Notable among these are Sandoz AG and Boehringer Ingelheim RCV GmbH & Co. KG. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in his field.

Collaborations

Michael has collaborated with esteemed colleagues, including Alois A. Jungbauer and Rainer Hahn. These partnerships have fostered a collaborative environment that has led to innovative solutions in the realm of affinity ligands.

Conclusion

Michael Seifert's contributions to the field of affinity ligands exemplify the impact of innovative thinking in biotechnology. His patent and collaborations highlight the importance of teamwork in advancing scientific knowledge.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…